Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Castle Biosciences, Inc.
Castle Biosciences to Present at the Canaccord Genuity 46th Annual Growth Conference
July 22, 2026
Castle Biosciences Announces New York State Department of Health Approval of its AdvanceAD-Tx™ Test
July 14, 2026
Castle Biosciences to Release Second Quarter 2026 Financial Results and Host Webcast on Thursday, July 30, 2026
July 9, 2026
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
Castle Biosciences’ Chief Financial Officer Frank Stokes Named a 2026 CFO Awards Honoree by the Houston Business Journal
June 23, 2026
Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 19, 2026
Castle Biosciences’ TissueCypher® Test Surpasses 100,000 Orders, Advancing Precision Risk Assessment for Patients with Barrett’s Esophagus
June 16, 2026
Castle Biosciences Reports First Quarter 2026 Results
May 8, 2026
New Data at DDW 2026 Show TissueCypher® Testing Improves Risk Stratification and Drives Risk-Aligned Management in Barrett’s Esophagus
May 5, 2026
Castle Biosciences Supports Nationwide Patient Advocacy and Screening Initiatives to Celebrate Skin Cancer Awareness Month
May 5, 2026
1
2
3
Next Page
→